Here's my pick for the best stock to buy right now with recession fears rising. Vertex Pharmaceuticals (NASDAQ: VRTX) has soared close to 30%, absolutely trouncing the S&P 500. How has Vertex seemingly defied gravity?
Vertex Pharmaceuticals (VRTX) closed at $283.45 in the latest trading session, marking a -1.01% move from the prior day.
Vertex Pharmaceuticals (NASDAQ: VRTX) is a monster stock because it's the undisputed master of the market for cystic fibrosis (CF) therapies. There are only about 25,000 CF patients in the Western world that are eligible but not currently enrolled in treatment with any of the company's six therapies for the condition. Vertex is advancing with commercial efforts to access that untapped market, not to mention chasing an even smaller population of around 5,000 patients for whom wholly new medicines are being developed.